Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Spotlight on the delivery of photosensitizers: different approaches for photodynamic-based therapies

Full text
Author(s):
Pellosi, Diogo Silva [1] ; Carvalho De Jesus, Priscila da Costa [2] ; Tedesco, Antonio Claudio [1]
Total Authors: 3
Affiliation:
[1] Univ Sao Paulo, Dept Chem, Lab Photobiol & Photomed, Ctr Nanotechnol & Tissue Engn, Ribeirao Preto, SP - Brazil
[2] Univ Sao Paulo, Dept Chem Engn, Polytech Sch EPUSP, Sao Paulo, SP - Brazil
Total Affiliations: 2
Document type: Journal article
Source: Expert Opinion on Drug Delivery; v. 14, n. 12, p. 1395-1406, 2017.
Web of Science Citations: 6
Abstract

Introduction: Nanomedicine development allowed the discovery of new photosensitizers (PS) and drug delivery systems (DDS) to overcome current issues on phototherapy. Nano-engineered materials have the potential to improve the solubility of PS, control drug pharmacokinetics, decreasing side effects, increasing bioavailability, and overcoming multidrug resistance. A recent approach is the co-delivery of PS with other therapeutic agents in a multimodal platform for synergic and improved results. Areas covered: This paper discusses the delivery of PS-nanostructured platforms for conventional, photothermal, and antimicrobial photodynamic therapies, as well as in a recent therapeutic modality for photobiomodulation, covering applications of cancer diagnosis, targeting to skin pathogens, photoregeneration and wound healing. The focus of the present review is to describe the use of different DDS to enhance the therapeutic outcomes triggered by the combination of delivered PS, light, and oxygen. Expert opinion: Nanotechnology allowed the development of site-specific delivery of PS molecules, expanding possibilities poorly explored before to enhance photodynamic efficacy and extrapolate the concept to other treatment protocols. Research in this area embraces potential and pitfalls of PS delivery, allowing new clinical phase outcomes and long-term issues to be established, which will impact on several biomedical applications. (AU)

FAPESP's process: 13/50181-1 - Use of drugs containing nanocarriers with photosensitizers and/or other active compounds applied to cell therapy and treatment of central nervous system disorders
Grantee:Antonio Claudio Tedesco
Support Opportunities: Research Projects - Thematic Grants